AI IntelligenceMay 9, 2026Primary Market
Article
Calidi Biotherapeutics, Inc. · Undisclosed · Unbekannt
Calidi Biotherapeutics filed an 8-K reporting entry into a material definitive agreement and unregistered sales of equity securities, indicating a potential capital raise.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Calidi Biotherapeutics filed an 8-K reporting entry into a material definitive agreement and unregistered sales of equity securities, indicating a potential capital raise.